4 TECH OUTLOOKFebruary - 2020Intricacies of Precision MedicineIN MY OPINION12Andrew Garrett, PhD, Executive Vice President, Scientific Operations, ICON Clinical Research [NASDAQ: ICLR]08LAST WORDDarryl McConnell, SVP, Research Site Head Austria, Boehringer IngelheimThe Need for Innovation in Drug Discovery34COVER STORYDEVELOPING FINE CHEMICALS FOR THE LIFE SCIENCESTHIERRY DURAND, MANAGING DIRECTOR
< Page 3 | Page 5 >